Login

Financial Snapshot

Revenue
TTM
$2.709B
Gross Margin
TTM
18.89%
Net Income
TTM
-$446.9M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
94.88%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$525.9M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$190.4M

Stock Price

Loading...
Market Cap: $1.4786 Billion

About Fortrea Holdings Inc

Fortrea Holdings Inc (NASDAQ: FTRE) is a contract research organization that provides clinical development and laboratory services to biopharmaceutical, medical device, and diagnostic companies. The filing excerpts provided do not contain sufficient specific financial data, segment breakdowns, revenue figures, customer concentration details, or competitive positioning information to support a fuller canonical description grounded in the 10-K filed 2026-02-26 (accession 000162828026012244). The excerpts include only cover page and boilerplate forward-looking statement language, with key financial and business detail sections returning redacted or unpopulated content. No specific revenue, headcount, segment mix, geographic breakdown, or named competitor data is available from the provided excerpts to include without violating source-grounding rules.

Source: SEC 10-K, filed 2026-02-26

Industry: Services-Medical Laboratories Peers: 10X Genomics Inc Azenta Inc Cytek Biosciences Inc Maravai LifeSciences Holdings Inc Pacific Biosciences of California Inc Quanterix Corp Sotera Health Co Thermo Fisher Scientific Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support